FDA’s Purple Book provides a searchable database of licensed biological products and includes the patent information provided to biosimilar applicants during the BPCIA patent dance. As we previously ...
In 2021, the FDA’s Purple Book went live, providing a searchable database of licensed biological products, including the patent information provided to biosimilar applicants during the patent dance.
The US House of Representatives on Wednesday unanimously passed two bills that would increase the utility of the US Food and Drug Administration’s (FDA) Orange Book for generic drugmakers and Purple ...
If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. Amazon has the original Alice Walker novel available for ...
The US Food and Drug Administration (FDA) on Monday updated its searchable Purple Book database to include all biologics regulated by its Center for Drug Evaluation and Research (CDER) with the ...
“Reference biologic drug makers until recently faced no obligation to disclose to the public the patents associated with their licensed biologic products…. This disparity between the Hatch-Waxman and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results